Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation IQWiG. Alipogentiparvovec – bewertung gemäß § 35a abs. 1 satz 10 SGB V. [Alipogene tiparvovec - assessment according to §35a (para. 1, sentence 10) Social Code Book V (dossier assessment)] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 273. 2015 Indexing Status Subject indexing assigned by CRD MeSH Humans; Hyperlipoproteinemia Type I Costs Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32015001044 Date abstract record published 21/10/2015 |
